Document XOvR3x2vwmgVVDzGbVn2DzK6G

Final August 23, 2002 BHRC Oversight Committee Call Summary August 5, 2002 Participants: Patrick Beatty, ChevronTexaco Bill Broddle, Conoco Don Burnett, BP Patsy Clegg, Shell Lynn Russo, ExxonMobil Paula Podhasky, API Matt Todd, API George Woodall, API John Wagner, API Susan Hahn, API Communications Committee (CC) Update Key messages document has been circulated, comments have been received from Technical (TC) and Oversight (OC) Committees. PowerPoint Presentation is being finalized by APCO and will be circulated to the communications committee for comment www.shanghaihealthstudy.orgwebsite being reviewed by communications committee Next scheduled communications conference call is September 3, 2002 at 2pm EDT. Technical Update: Role of Regulators and NGOs: Technical Committee recommended that regulators and NGO's participate "as members of an expanded Technical committee" with participation in meetings restricted to technical issues as opposed to financial. The level to which the NGO or regulator can expect to participate will be defined in their invite letter. (Participant versus observer role will be clarified in "Roles and Responsibilities" document) Program milestones/Timeline: The Technical Committee is reviewing the information forwarded by PIs for timing and phase overlaps. It was noted that for the o Case-control study - timing will be based on accrual of 500 cases. o Disease progression -The case-control aspects of this study for AML, MDS, Aplastic anemia and benzene poisoning will be tracked based upon case accrual. PIs will be requested to estimate dates for mid term publications. o Molecular epidemiology - .The degree of overlap of the study phases based upon dates supplied by the PIs was unclear. PIs will be requested to clarify overlap, especially regarding Phases 2A & 2B. PIs will also be requested to estimate dates for mid term publications. SH ELL-MCCLU RG-059859